Safety of 100 µg venom immunotherapy rush protocols in children compared to adults

BACKGROUND: There is a paucity of studies examining the safety of venom immunotherapy (VIT) in children. We aimed to assess the incidence of anaphylactic side effects during rush VIT in a cohort of pediatric patients and adult controls. METHODS: 72 consecutive cycles of VIT-buildup in 71 children/ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Stoevesandt, Johanna, Hosp, Christine, Kerstan, Andreas, Trautmann, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506672/
https://www.ncbi.nlm.nih.gov/pubmed/28706538
http://dx.doi.org/10.1186/s13223-017-0204-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5506672/
https://www.ncbi.nlm.nih.gov/pubmed/28706538
http://dx.doi.org/10.1186/s13223-017-0204-y

Ejemplares similares